CBG Atlas

Safety & reporting
AtlasComparisonsCBN vs THC: What Ageing Changes
How we grade evidenceGlossaryCBG Monograph
Side by side

CBN vs THC: What Ageing Changes

Leave cannabis in a jar on a sunny windowsill long enough and some of its THC becomes CBN, with oxygen, heat, light and time doing the work. The two share an origin and little else. THC is strongly intoxicating, while CBN's cannabis-like effects have been mixed in people and mostly failed to appear at all (Corroon 2021). Established

Two ideas follow CBN around: that it is a milder THC, and that it helps people sleep. The chemistry says CBN is a different molecule rather than a milder THC, and human sleep trials missed their pre-specified endpoints.

Every statement below is graded by the evidence behind it. Legal notes are general, dated and not legal advice; this page makes no therapeutic claim for either compound.

At a glance

AttributeCBN (cannabinol)THC (Δ⁹-tetrahydrocannabinol)
Intoxicating?CBN (cannabinol)Not intoxicating, or weakly at most · Demonstrated · in vitroTHC (Δ⁹-tetrahydrocannabinol)Yes, strongly · Established
How it formsCBN (cannabinol)THC oxidises over time under oxygen, heat and light; no plant enzyme makes it · EstablishedTHC (Δ⁹-tetrahydrocannabinol)Heat decarboxylates THCA into THC · Established
Molecular formulaCBN (cannabinol)C₂₁H₂₆O₂ (CAS 521-35-7; PubChem CID 2543)THC (Δ⁹-tetrahydrocannabinol)C₂₁H₃₀O₂ (CAS 1972-08-3)
Cannabinoid-receptor activityCBN (cannabinol)Weak in laboratory studies · Demonstrated · in vitroTHC (Δ⁹-tetrahydrocannabinol)A partial agonist that activates CB₁ · Established
Standard drug testCBN (cannabinol)Can cause a positive. CBN may cross-react with THC immunoassays, and products can carry trace THC · EstablishedTHC (Δ⁹-tetrahydrocannabinol)Detected through its metabolite THC-COOH · Established
US legal status (general, dated; not legal advice)CBN (cannabinol)Generally federally legal when hemp-derived at ≤0.3% Δ⁹-THC (2018 Farm Bill); state rules varyTHC (Δ⁹-tetrahydrocannabinol)Federally controlled above 0.3% Δ⁹-THC by dry weight; state programs differ
SleepCBN (cannabinol)Human trials missed their pre-specified endpoints · Not supportedTHC (Δ⁹-tetrahydrocannabinol)This page makes no sleep claim
Figure P · targets side by side
CBN and THC at six targets: what our registry records, and where it records nothing
Six receptor and channel nodes in rows, with one column for CBN and one for THC. At CB1 cannabinoid receptor: CBN has no graded interaction in our registry; THC activates (partial agonist; in a review, no rung of its own; Pertwee 2008). At CB2 cannabinoid receptor: CBN has no graded interaction in our registry; THC activates (partial agonist; in a review, no rung of its own; Pertwee 2008). At α2-adrenoceptor: CBN has no graded interaction in our registry; THC has no graded interaction in our registry. At 5-HT1A serotonin receptor: CBN has no graded interaction in our registry; THC has no graded interaction in our registry. At TRPV1 and TRPV2 ion channels: CBN has no graded interaction in our registry; THC has no graded interaction in our registry. At TRPM8 ion channel: CBN has no graded interaction in our registry; THC has no graded interaction in our registry. CBN: no receptor-level record in our registry at any of the six targets; the registry is CBG-centred. Every recorded direction was measured in receptors, cells or tissue, or is quoted from a review; none is an effect in people, and none is a dose.How to read a cellblocksactivatesactivates, then desensitisesdamps activationrecorded in a review, direction qualified by the source, no rung of its ownno graded interaction in our registryCBNCannabinolTHCΔ9-tetrahydrocannabinolCB1CBN: no graded interactionin our registrya gold ring with a dot: recorded in a review, direction qualified by the source, no rung of its ownTHC activatespartial agonistin a review, no rung of its own · Pertwee 2008CB2CBN: no graded interactionin our registrya gold ring with a dot: recorded in a review, direction qualified by the source, no rung of its ownTHC activatespartial agonistin a review, no rung of its own · Pertwee 2008α2-adrenoceptorCBN: no graded interactionin our registryTHC: no graded interactionin our registry5-HT1ACBN: no graded interactionin our registryTHC: no graded interactionin our registryTRPV1 · TRPV2CBN: no graded interactionin our registryTHC: no graded interactionin our registryTRPM8CBN: no graded interactionin our registryTHC: no graded interactionin our registryCBN: no receptor-level record in our registry at any of these six targets.The registry is CBG-centred, and an empty column shows that rather than hides it. Absence of a record is not evidence of no interaction.
How to read a cell
An oxblood ring holds the direction: a bar: blocks; a chevron: activates; a chevron with a bar: activates, then desensitises; two bars: damps activation. A gold ring with a dot: recorded in a review, direction qualified by the source, no rung of its own. A dashed frame: no graded interaction in our registry.
CB1 cannabinoid receptor
CBN: no graded interaction in our registry. THC: activates (partial agonist), in a review, no rung of its own study type: Review Pertwee 2008.
CB2 cannabinoid receptor
CBN: no graded interaction in our registry. THC: activates (partial agonist), in a review, no rung of its own study type: Review Pertwee 2008.
α2-adrenoceptor
CBN: no graded interaction in our registry. THC: no graded interaction in our registry.
5-HT1A serotonin receptor
CBN: no graded interaction in our registry. THC: no graded interaction in our registry.
TRPV1 and TRPV2 ion channels
CBN: no graded interaction in our registry. THC: no graded interaction in our registry.
TRPM8 ion channel
CBN: no graded interaction in our registry. THC: no graded interaction in our registry.
A gold frame is a direction the registry holds only through a review, quoted with the qualification the source itself attaches; it carries no rung of its own. A dashed frame means the registry holds no graded interaction there, which is not the same as evidence of none. None of this is an effect in people, and none of it is a dose. CBN has no receptor-level record in our registry at any of the six targets: the registry is CBG-centred, and the empty column says so. Sources: Pertwee 2008. CBG's record at researcher depth is on the monograph's target map; the receptors themselves are drawn on the ECS map →

What's actually established

Oxidation explains most of what matters here, from the molecule itself to what a COA can tell a buyer.

  • Shared origin, separate molecule. THC breaks down by oxidation into CBN as it ages. What comes out is a chemically different, fully aromatised molecule, and calling it a milder THC gets the chemistry wrong. Established
  • Intoxication. THC intoxicates strongly. CBN is non-intoxicating or weakly intoxicating at most, and laboratory studies find only weak activity at cannabinoid receptors. Demonstrated · in vitro
  • Why aged cannabis holds more CBN. Fresh plants contain only traces. Oxygen, heat, light and time convert THC into CBN, so a CBN reading on a COA is also a clue to how old the material is and how it was stored. Established
  • Drug testing. Standard tests look for THC and its metabolites, yet CBN can cross-react with some THC immunoassays, and CBN products can carry trace THC. A positive is a real risk. Established
  • Legal status (general, dated; not legal advice). As of 2026 in the US, the 2018 Farm Bill makes hemp-derived CBN federally legal as long as the product contains at most 0.3% Δ⁹-THC by dry weight. THC above that threshold is federally controlled. State laws differ, and they move. [Legal snapshot · not legal advice]
  • CBN and sleep. Human trials of CBN for sleep missed the endpoints they had pre-specified (Bonn-Miller 2024; Lavender 2026). The claim was tested and came up short, so a sleep claim on a CBN label now runs against the evidence. Not supported

Common questions

Does CBN get you high like THC?

Not the way THC does. CBN is generally regarded as non-intoxicating or, at most, weakly intoxicating, and laboratory studies find its activity at cannabinoid receptors to be weak. THC's characteristic high stays with THC. Demonstrated · in vitro

Is CBN just old THC?

Essentially, yes: CBN is what THC becomes as it degrades through oxidation. Given oxygen, heat, light and time, THC slowly converts to CBN, which is why aged or badly stored cannabis carries more CBN than fresh flower. Established

Is CBN a weaker version of THC?

No. CBN is a chemically different, fully aromatised molecule, with the formula C₂₁H₂₆O₂ against THC's C₂₁H₃₀O₂. The two share an origin, and the family resemblance stops there. Established

Will CBN show up on a drug test like THC?

It can. Standard tests look for THC and its metabolites, and CBN can cross-react with some THC immunoassays. CBN products may also contain trace THC, so anyone subject to testing should treat them as a real risk. Established

Is CBN or THC better for sleep?

This page backs neither. It makes no sleep claim for THC, and CBN's claim was tested in human trials that missed their pre-specified endpoints (Bonn-Miller 2024; Lavender 2026), which is why CBN is graded Not-supported. Not medical advice. Not supported

Informational only — not our claims, and not advice. The statements on this page about potential effects, benefits, or uses reflect claims made by third parties (manufacturers, media, traditional use, or preliminary research) and are presented for educational and informational purposes only. CBG Atlas does not make, adopt, endorse, or affirm these claims, and does not represent them as fact. These statements have not been evaluated by the Food and Drug Administration (or any regulator) and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is medical, legal, or professional advice; cannabinoid effects, safety, and legal status vary by person, product, and jurisdiction and can change over time. Consult a qualified professional before making any health or purchasing decision. Where we can, we show how strong the evidence is and cite the source; where evidence is thin or absent, we say so. Peregrine Biopharma funds the platform and holds no editorial authority.

Sources

  • Corroon et al. (2021). Cannabinol and Sleep: Separating Fact from Fiction. Cannabis Cannabinoid Res. PMID 34468204.
  • Bonn-Miller et al. (2024). A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Exp Clin Psychopharmacol. PMID 37796540.
  • Lavender et al. (2026). Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial. J Sleep Res. PMID 41698831.

Before you act on what you have read

Informational only, not medical advice. CBG Atlas is a scientific reference. Nothing here diagnoses, treats, cures or prevents any disease. Every claim on the page carries the grade of the evidence behind it, and the grade sets the words the claim may use. How we grade evidence.

Each grade rates the support for a claim across the literature. It does not rate any single study. An effect in cells may never show up in people. The grades cover the studies checked up to 9 August 2026. This page is for information and is not medical advice.

Cardiovascular note. CBG is a potent α2-adrenoceptor agonist in vitro, and α2 agonism can lower blood pressure. Anyone taking blood-pressure or other cardiovascular medication should consult a clinician before use. This is educational information, not medical advice.

Funding and independence. Peregrine Biopharma funds the platform and holds no editorial authority.

Report a safety event →

Keep exploring

The compounds compared

More comparisons